Mavupharma logo

Mavupharma Inc.

Mavupharma is developing non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://mavupharma.com
Founded2016
Disease Focus
Development Stage
STOCK CODENon Listed
Address
5400 Carillon PointBuilding 5000 4th FloorKirkland, WA 98033
Washington
United States
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]